Autoimmune diseases, immune modulation, inflammation, and self-tolerance
223 Artikel
New targeted therapies and biomarker-driven approaches are revolutionizing RA management, potentially improving healthspan for millions.
New research reveals how rheumatoid arthritis dramatically increases kidney disease risk through inflammation and medication effects.
New research reveals how KLF2 and KLF3 proteins regulate T cell movement and exhaustion, offering insights for immune system optimization.
New research reveals how tissue fibroblasts orchestrate age-related inflammation, creating exhausted T cells that increase vulnerability to disease.
New research reveals how specialized gut cells maintain protective immunity against parasites, offering insights into immune system optimization.
Women with RA using treat-to-target therapy achieved pregnancy 3x faster than those with standard care, with 77% conceiving within one year.
New research explores how pregnancy affects rheumatoid arthritis symptoms and long-term health outcomes for women.
Combining ixekizumab with tirzepatide achieved better joint health and significant weight loss compared to arthritis treatment alone.
Scientists identify key cellular pathways driving lupus, revealing promising new therapeutic targets beyond current treatments.
New cell-based treatments including CAR-T therapy could transform outcomes for systemic sclerosis patients.
New research reveals why giving multiple doses of a promising type 1 diabetes treatment doesn't improve outcomes beyond a single course.
New research reveals how a single antibody treatment creates lasting protection against autoimmune diabetes by reshaping immune cells.
